1. Home
  2. FOXX vs LSTA Comparison

FOXX vs LSTA Comparison

Compare FOXX & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

N/A

Current Price

$1.40

Market Cap

17.3M

Sector

N/A

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$1.20

Market Cap

15.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FOXX
LSTA
Founded
2017
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
15.9M
IPO Year
2025
2000

Fundamental Metrics

Financial Performance
Metric
FOXX
LSTA
Price
$1.40
$1.20
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
8.9K
★ 108.7K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.42
EPS
N/A
★ N/A
Revenue
★ $52,584,432.00
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 56.90
52 Week Low
$1.28
$0.96
52 Week High
$7.90
$5.07

Technical Indicators

Market Signals
Indicator
FOXX
LSTA
Relative Strength Index (RSI) 21.73 56.44
Support Level N/A $1.23
Resistance Level $2.77 $1.28
Average True Range (ATR) 0.19 0.12
MACD -0.05 0.04
Stochastic Oscillator 3.03 56.18

Price Performance

Historical Comparison
FOXX
LSTA

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: